A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants

Condition:   Renal Insufficiency Interventions:   Drug: Lanabecestat;   Drug: Iohexol Sponsors:   Eli Lilly and Company;   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials